The impact of ICAM-1, CCL2 and TGM2 gene polymorphisms on differentiation syndrome in acute promyelocytic leukemia

BACKGROUND: Although arsenic trioxide (ATO) and all-trans retinoic acid (ATRA) are well-tolerated and effective treatments for Acute Promyelocytic Leukemia (APL), Differentiation Syndrome (DS) is a lethal side effect in some patients. The pathogenesis of DS is complex and not well understood; howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammadzadeh, Zahra, Omidkhoda, Azadeh, Chahardouli, Bahram, Hoseinzadeh, Ghazaleh, Moghaddam, Kamran Ali, Mousavi, Seyed Asadollah, Rostami, Shahrbano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797108/
https://www.ncbi.nlm.nih.gov/pubmed/33422029
http://dx.doi.org/10.1186/s12885-021-07783-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797108/
https://www.ncbi.nlm.nih.gov/pubmed/33422029
http://dx.doi.org/10.1186/s12885-021-07783-y

Ejemplares similares